Abstract
A thorough literature review on current research for trisomy 21 detection using ultrasound will be carried out for existing modality’s drawback investigation. Due to its critical restriction, computing on ultrasound markers in term of its recognition, segmentation and measurement are essentially required. 3D reconstruction of nuchal translucency becomes a breakthrough to select the appropriate scanning plane of ultrasound markers. It shall resolve the problematic issue on scanning plane selections which depends on operator assumption and experience. Data sources from hospital patient scanning should obtain the approval from Medicine ethical committee. Consent and simple agreement document shall be prepared. The main ultrasound images sources will be taken from Health Center Universiti Teknologi Malaysia, Hospital Universiti Sains Malaysia, and Hospital Universiti Kebangsaan Malaysia. External collaboration parties are Hospital Sultanah Aminah and Technische Universitat Ilmenau, Germany. Other than fetal data, maternal health data will also be recorded. This data is important to obtain the knowledge of correlation between fetal and mother data. It is recommended that pregnant women should be older than 30 years old. This chapter will describe the book in terms of its background, history and the related works in greater detail. The focus will be on the Trisomy 21 background, history, existing detection techniques, and ultrasound application using 2D and 3D image formation on fetal abnormalities detection. Previous related research works are discussed and each of their limitation is remarked.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aarnink, R. G., Huynen, A. L., Giesen, R. J. B., Delarosette, J., Debruyne, F. M. J., & Wijkstra, H. (1995). Automated prostate volume determination with ultrasonographic imaging. Journal of Urology, 153(5), 1549–1554.
Abele, H., Hoopmann, M., Wright, D., Hoffmann-Poell, B., Huettelmaier, M., Pintoffl, K., et al. (2010). Intra- and interoperator reliability of manual and semi-automated measurement of fetal nuchal translucency by sonographers with different levels of experience. Ultrasound in Obstetrics and Gynecology, 36(4), 417–422.
Abuhamad, A. (2005). Technical aspects of nuchal translucency measurement. Seminars in Perinatology, 29(6), 376–379.
Allott, C. P., Barry, C. D., Pickford, R., & Waterton, J. C. (1999). Volumetric assessment of carotid artery bifurcation using freehand-acquired, compound 3D ultrasound. British Journal of Radiology, 72(855), 289–292.
Arbeille, P., Eder, V., Casset, D., Quillet, L., Hudelo, C., & Herault, S. (2000). Real-time 3-D ultrasound acquisition and display for cardiac volume and ejection fraction evaluation. Ultrasound in Medicine and Biology, 26(2), 201–208.
Baba, K., Okai, T., Kozuma, S., & Taketani, Y. (1999). Fetal abnormalities: evaluation with real-time-processible three-dimensional US—preliminary report. Radiology, 211(2), 441–446.
Basset, O., Gimenez, G., Mestas, J. L., Cathignol, D., & Devonec, M. (1991). Volume measurement by ultrasonic transverse or sagittal cross-sectional scanning. Ultrasound in Medicine and Biology, 17(3), 291–296.
Bekker, M. N., Twisk, J. W. R., & van Vugt, J. M. G. (2004). Reproducibility of the fetal nasal bone length measurement. Journal of Ultrasound in Medicine, 23(12), 1613–1618.
Bernardino, F., Cardoso, R., Montenegro, N., Bernardes, J., & de Sa, J. M. (1998). Semiautomated ultrasonographic measurement of fetal nuchal translucency using a computer software tool. Ultrasound in Medicine and Biology, 24(1), 51–54.
Blaas, H. G., Eik-Nes, S. H., Berg, S., & Torp, H. (1998). In vivo three-dimensional ultrasound reconstructions of embryos and early fetuses. Lancet, 352(9135), 1182–1186.
Bonillamusoles, F., Raga, F., Osborne, N. G., & Blanes, J. (1995). Use Of 3-dimensional ultrasonography for the study of normal and pathological morphology of the human embryo and fetus—preliminary-report. Journal of Ultrasound in Medicine, 14(10), 757–765.
Braithwaite, J. M., & Economides, D. L. (1995). The measurement of nuchal translucency with transabdominal and transvaginal sonography—success rates, repeatability and levels of agreement. British Journal of Radiology, 68(811), 720–723.
Bulletins, A. C. o. P. (2007). Acog practice bulletin no. 77: Screening for fetal chromosomal abnormalities. Obstetrics and gynecology, 109(1), 217–227.
Catanzariti, E., Fusco, G., Isgrò, F., Masecchia, S., Prevete, R., & Santoro, M. (2009). A semi-automated method for the measurement of the fetal nuchal translucency in ultrasound images.
Cicero, S., Bindra, R., Rembouskos, G., Spencer, K., & Nicolaides, K. H. (2003a). Integrated ultrasound and biochemical screening for trisomy 21 using fetal nuchal translucency, absent fetal nasal bone, free Beta-Hcg and Papp-A At 11 To 14 weeks. Prenatal Diag, 23(4), 306–310.
Cicero, S., Dezerega, V., Andrade, E., Scheier, M., & Nicolaides, K. H. (2003b). Learning curve for sonographic examination of the fetal nasal bone at 11–14 weeks. Ultrasound in Obstetrics and Gynecology, 22(2), 135–137.
Cullen, M. T., Green, J. J., Reece, E. A., & Hobbins, J. C. (1989). A comparison of trans-vaginal and abdominal ultrasound in visualizing the 1st trimester conceptus. Journal of Ultrasound in Medicine, 8(10), 565–569.
Down, J. L. (1995). Observations on an Ethnic classification of idiots. Mental Retardation, 33(1), 54–56.
Downey, D. B., Nicolle, D. A., Levin, M. F., & Fenster, A. (1996). Three-dimensional ultrasound imaging of the eye. Eye, 10, 75–81.
Fenster, A., & Downey, D. B. (1996). 3-D ultrasound imaging: a review. IEEE Engineering in Medicine and Biology Magazine, 15(6), 41–51.
Fenster, A., Tong, S., Sherebrin, S., Downey, D. B., & Rankin, R. N. (1995). Three-dimensional ultrasound imaging. Proceedings of SPIE, 2432, 176–184.
Fenster, A., Downey, D. B., & Cardinal, H. N. (2001). Three-dimensional ultrasound imaging. Physics in Medicine & Biology, 46(5), R67–R99.
Gopal, A. S., Schnellbaecher, M. J., Shen, Z. Q., Akinboboye, O. O., Sapin, P. M., & King, D. L. (1997). Freehand three-dimensional echocardiography for measurement of left ventricular mass: in vivo anatomic validation using explanted human hearts. Journal of the American College of Cardiology, 30(3), 802–810.
Hafner, E., Philipp, T., Schuchter, K., Dillinger-Paller, B., Philipp, K., & Bauer, P. (1998). Second-trimester measurements of placental volume by three-dimensional ultrasound to predict small-for-gestational-age infants. Ultrasound in Obstetrics and Gynecology, 12(2), 97–102.
Howe, D., Wheeler, T., & Perring, S. (1994). Measurement of placental volume with real-time ultrasound in mid-pregnancy. Journal of Clinical Ultrasound, 22(2), 77–83.
Huether, C. A., Ivanovich, J., Goodwin, B. S., Krivchenia, E. L., Hertzberg, V. S., Edmonds, L. D., et al. (1998). Maternal age specific risk rate estimates for down syndrome among live births in whites and other races from Ohio and Metropolitan Atlanta, 1970–1989. Journal of Medical Genetics, 35(6), 482–490.
Hyett, J. A., Moscoso, G., & Nicolaides, K. H. (1995). Cardiac defects in 1st-trimester fetuses with trisomy 18. Fetal Diagnosis and Therapy, 10(6), 381–386.
Kagan, K. O., Wright, D., Spencer, K., Molina, F. S., & Nicolaides, K. H. (2008). First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: Impact of maternal and pregnancy characteristics. Ultrasound in Obstetrics and Gynecology, 31(5), 493–502.
Kagan, K. O., Cicero S., et al (2009). Fetal nasal bone in screening for trisomies 21, 18 and 13 and Turner syndrome at 11–13 weeks of gestation. Ultrasound in Obstetrics and Gynecology, 33(3):259–264.
Kampmann, W., Walka, M. M., Vogel, M., & Obladen, M. (1998). 3-D sonographic volume measurement of the cerebral ventricular system: In vitro validation. Ultrasound in Medicine and Biology, 24(8), 1169–1174.
Kanellopoulos, V., Katsetos, C., & Economides, D. L. (2003). Examination of fetal nasal bone and repeatability of measurement in early pregnancy. Ultrasound in Obstetrics and Gynecology, 22(2), 131–134.
Kelly, I. M. G., Gardener, J. E., & Lees, W. R. (1992). 3-Dimensional Fetal Ultrasound. Lancet, 339(8800), 1062–1064.
Kornman, L. H., Morssink, L. P., Beekhuis, J. R., deWolf, B., Heringa, M. P., & Mantingh, A. (1996). Nuchal translucency cannot be used as a screening test for chromosomal abnormalities in the first trimester of pregnancy in a routine ultrasound practice. Prenatal Diag, 16(9), 797–805.
Laudy, J. A. M., Janssen, M. M. M., Struyk, P. C., Stijnen, T., Wallenburg, H. C. S., & Wladimiroff, J. W. (1998). Fetal liver volume measurement by three-dimensional ultrasonography: a preliminary study. Ultrasound in Obstetrics and Gynecology, 12(2), 93–96.
Lee, Y.-B., & Kim, M.-H. (2006). Automated ultrasonic measurement of fetal nuchal translucency using dynamic programming. In J. Martínez-Trinidad., J. A. Carrasco Ochoa., & J. Kittler. (Eds.), Progress in Pattern Recognition, Image Analysis and Applications (Vol. 4225, pp. 157–167), Berlin/Heidelberg: Springer.
Lee, A., Deutinger, J., & Bernaschek, G. (1995). 3-dimensional ultrasound—abnormalities of the fetal face in surface and volume rendering mode. British Journal of Obstetrics and Gynaecology, 102(4), 302–306.
Lee, Y.-B., Kim, M.-J., & Kim, M.-H. (2007). Robust border enhancement and detection for measurement of fetal nuchal translucency in ultrasound images. Medical & Biological Engineering & Computing, 45(11), 1143–1152.
Leshin, L. (1997). Trisomy 21: The story of down syndrome. Health Issues: D-S health Down Syndrome.
Magni, G., Cao, Q. L., Sugeng, L., Delabays, A., Marx, G., Ludomirski, A., et al. (1996). Volume-rendered, three-dimensional echocardiographic determination of the size, shape, and position of atrial septal defects: validation in an in vitro model. American Heart Journal, 132(2), 376–381.
Malone, F. D., Ball, R. H., Nyberg, D. A., Comstock, C. H., Saade, G., Berkowitz, R. L., Dugoff, L., Craigo, S. D., Carr, S. R., Wolfe, H. M., Tripp, T., D’Alton, M. E., & Consortium, F. R. (2004). First-trimester nasal bone evaluation for aneuploidy in the general population. Obstetrics and gynecology, 104(6), 1222–1228.
Martin, R. W., Bashein, G., Detmer, P. R., & Moritz, W. E. (1990). Ventricular volume measurement from a multiplanar transesophageal ultrasonic-imaging system—an invitro study. IEEE Transactions on Biomedical Engineering, 37(5), 442–449.
Moratalla, J., Pintoffl, K., Minekawa, R., Lachmann, R., Wright, D., & Nicolaides, K. H. (2010). Semi-automated system for measurement of nuchal translucency thickness. Ultrasound in Obstetrics and Gynecology, 36(4), 412–416.
Nagdyman, N., Walka, M. M., Kampmann, W., Stöver, B., & Obladen, M. (1999). 3-D ultrasound quantification of neonatal cerebral ventricles in different head positions. Ultrasound in Medicine and Biology, 25(6), 895–900.
Nathan, M. S., Seenivasagam, K., Mei, Q., Wickham, J. E. A., & Miller, R. A. (1996). Transrectal ultrasonography: Why are estimates of prostate volume and dimension so inaccurate? British Journal of Urology, 77(3), 401–407.
Nicolaides, K. H., Azar, G., Byrne, D., Mansur, C., & Marks, K. (1992). Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ, 304(6831), 867–869.
Nicolaides, K. H., Brizot, M. L., & Snijders, R. J. M. (1994). Fetal nuchal translucency—ultrasound screening for fetal trisomy in the first trimester of pregnancy. British Journal of Obstetrics and Gynaecology, 101(9), 782–786.
Nicolaides, K., Sebire, N., & Snijders, R. (1999). The 11–14 weeks scan: the diagnosis of fetal abnormalities. New York, NY: Parthenon Publishing.
Nicolaides, K. H., Kagan, K. O., Wright, D., Baker, A., & Sahota, D. (2008). Screening for trisomy 21 by maternal age, fetal nuchal translucency thickness, free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A. Ultrasound in Obstetrics and Gynecology, 31(6), 618–624.
Ofili, E. O., & Nanda, N. C. (1994). 3-dimensional and 4-dimensional echocardiography. Ultrasound in Medicine and Biology, 20(8), 669–675.
Pandya, P. P., Brizot, M. L., Kuhn, P., Snijders, R. J. M., & Nicolaides, K. H. (1994). First-trimester fetal nuchal translucency thickness and risk for trisomies. Obstetrics and Gynecology, 84(3), 420–423.
Pandya, P. P., Altman, D. G., Brizot, M. L., Pettersen, H., & Nicolaides, K. H. (1995). Repeatability of measurement of fetal nuchal translucency thickness. Ultrasound in Obstetrics and Gynecology, 5(5), 334–337.
Paul, C., Krampl, E., Skentou, C., Jurkovic, D., & Nicolaides, K. H. (2001). Measurement of fetal nuchal translucency thickness by three-dimensional ultrasound. Ultrasound in Obstetrics and Gynecology, 18(5), 481–484.
Perona, P., & Malik, J. (1990). Scale-space and edge detection using anisotropic diffusion. Pattern analysis and machine intelligence. IEEE Transactions On, 12(7), 629–639.
Pohls, U. G., & Rempen, A. (1998). Fetal lung volumetry by three-dimensional ultrasound. Ultrasound in Obstetrics and Gynecology, 11(1), 6–12.
Rankin, R. N., Fenster, A., Downey, D. B., Munk, P. L., Levin, M. F., & Vellet, A. D. (1993). Three-dimensional sonographic reconstruction: techniques and diagnostic applications. American Journal of Roentgenology, 161(4), 695–702.
Roberts, L. J., Bewley, S., Mackinson, A. M., & Rodeck, C. H. (1995). First trimester fetal nuchal translucency—problems with screening the general-population. 1. British Journal of Obstetrics and Gynaecology 102(5), 381–385.
Rosenfield, K., Boffetti, P., Kaufman, J., Weinstein, R., Razvi, S., & Isner, J. M. (1992). 3-dimensional reconstruction of human carotid arteries from images obtained during noninvasive B-mode ultrasound examination. American Journal of Cardiology, 70(3), 379–384.
Salustri, A., & Roelandt, J. (1995). Ultrasonic 3-dimensional reconstruction of the heart. Ultrasound in Medicine and Biology, 21(3), 281–293.
Schild, R. L., Wallny, T., Fimmers, R., & Hansmann, M. (1999). Fetal lumbar spine volumetry by three-dimensional ultrasound. Ultrasound in Obstetrics and Gynecology, 13(5), 335–339.
Snijders, R. J. M., Noble, P., Sebire, N., Souka, A., Nicolaides, K. H., & Grp, F. M. F. F. T. S. (1998). Uk multicentre project on assessment of risk of trisomy 21 by maternal age and fetal nuchal-translucency thickness at 10–14 weeks of gestation. Lancet, 352(9125), 343–346.
Snijders, R. J. M., Sundberg, K., Holzgreve, W., Henry, G., & Nicolaides, K. H. (1999). Maternal age- and gestation-specific risk for trisomy 21. Ultrasound in Obstetrics and Gynecology, 13(3), 167–170.
Souka, A. P., Krampl, E., Bakalis, S., Heath, V., & Nicolaides, K. H. (2001). Outcome of pregnancy in chromosomally normal fetuses with increased nuchal translucency in the first trimester. Ultrasound in Obstetrics and Gynecology, 18(1), 9–17.
Wee L. K., Lim M., & Supriyanto, E. (2010a). Automated Risk Calculation For Trisomy 21 Based On Maternal Serum Markers Using Trivariate Lognormal Distribution. Proceedings of the 12th WSEAS International Conference on Automatic Control, Modelling & Simulation (ACMOS 2010). pp. 327–332.
Taipale, P., Hiilesmaa, V., Salonen, R., & Ylostalo, P. (1997). Increased nuchal translucency as a marker for fetal chromosomal defects. New England Journal of Medicine, 337(23), 1654–1658.
Terris, M. K., & Stamey, T. A. (1991). Determination of prostate volume by transrectal ultrasound. Journal of Urology, 145(5), 984–987.
Ville (2010). Semi-automated measurement of nuchal translucency thickness: Blasphemy or oblation to quality? Ultrasound in Obstetrics & Gynecology. 36(4), 400–403.
Wald, N. J., George, L., Smith, D., Densem, J. W., & Pettersonm, K. (1996). On behalf of the International Prenatal Screening Research, G. Serum Screening For Down’s Syndrome Between 8 And 14 Weeks Of Pregnancy. BJOG: An International Journal of Obstetrics & Gynaecology, 103(5), 407–412.
Wald, N. J., Rodeck, C., Hackshaw, A. K., Walters, J., Chitty, L., Mackinson, A. M., & Group, S. R. (2003). First and second trimester antenatal screening for down’s syndrome: the results of the serum, urine and ultrasound screening study (suruss). Health Technology Assessment (Winchester, England), 7(11), 1–77.
Wee, L. K., Miin, L., & Supriyanto, E. (2010). Automated trisomy 21 assessment based on maternal serum markers using trivariate lognormal distribution. WSEAS Transactions on Systems, 9(8), 844–853.
Wee, L. K., Chai, H. Y., & Supriyanto, E. (2011). Computerized nuchal translucency three dimensional reconstruction, visualization and measurement for trisomy 21 prenatal early assessment. International Journal of Physical Sciences, 6(19), 4640–4648.
Zosmer, N., Souter, V. L., Chan, C. S. Y., Huggon, I. C., & Nicolaides, K. H. (1999). Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency. BJOG: An International Journal of Obstetrics & Gynaecology, 106(8), 829–833.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2013 The Author(s)
About this chapter
Cite this chapter
Lai, K.W., Supriyanto, E. (2013). Medicine and Engineering Related Researches on the Utility of Two Dimensional Nuchal Translucency. In: Detection of Fetal Abnormalities Based on Three Dimensional Nuchal Translucency. SpringerBriefs in Applied Sciences and Technology. Springer, Singapore. https://doi.org/10.1007/978-981-4021-96-8_2
Download citation
DOI: https://doi.org/10.1007/978-981-4021-96-8_2
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-4021-95-1
Online ISBN: 978-981-4021-96-8
eBook Packages: EngineeringEngineering (R0)